-
公开(公告)号：US20170304296A1
公开(公告)日：2017-10-26
申请号：US15520752
申请日：2015-10-21
发明人： RAGHU CAVATUR , KEVIN CHEN , MATTHEW JAMES KASER , HONGCHUN QIU
IPC分类号： A61K31/485 , A61K47/36 , A61K47/32 , A61K47/26 , A61K47/20 , A61K47/12 , A61K47/02 , A61K45/06 , A61K31/192 , A61K47/38 , A61K31/09
CPC分类号： A61K31/485 , A61K9/2054 , A61K9/209 , A61K31/09 , A61K31/137 , A61K31/192 , A61K45/06 , A61K47/02 , A61K47/12 , A61K47/20 , A61K47/26 , A61K47/32 , A61K47/36 , A61K47/38 , A61K2300/00
摘要： The present invention is directed to a pharmaceutical composition comprising a pharmaceutically effective amount of guaifenesin, naproxen and at least one further active which is selected to be an antitussive, a decongestant or an antihistamine.
-
公开(公告)号：US20200261373A1
公开(公告)日：2020-08-20
申请号：US16866136
申请日：2020-05-04
IPC分类号： A61K9/48 , A61K45/06 , A61K9/20 , A61K31/485 , A61K31/192 , A61K31/09
摘要： The present invention is directed to an oral pharmaceutical dosage form comprising a capsule containing at least two tablets, each tablet containing at least one different pharmaceutically active ingredient
-
公开(公告)号：US20170304210A1
公开(公告)日：2017-10-26
申请号：US15520731
申请日：2015-10-21
IPC分类号： A61K9/48 , A61K31/192 , A61K31/09 , A61K9/20 , A61K31/485
CPC分类号： A61K9/4808 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2054 , A61K9/2059 , A61K31/09 , A61K31/192 , A61K31/485 , A61K45/06 , A61K2300/00
摘要： The present invention is directed to an oral pharmaceutical dosage form comprising a capsule containing at least two tablets, each tablet containing at least one different pharmaceutically active ingredient
-
-
搜索结果
3 条记录 (耗时 0.017 秒)
